Zachary L. Skidmore

发表

CIViC: A knowledgebase for expert-crowdsourcing the clinical interpretation of variants in cancer

Obi L. Griffith, Steven J. M. Jones, Benjamin M. Good, 2016, bioRxiv.

Development of a precision oncology single molecule molecular inversion probe (smMIP) panel using a community-consensus approach

Malachi Griffith, Obi L. Griffith, Zachary L. Skidmore, 2018 .

Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples

Obi L. Griffith, Malachi Griffith, Nicholas C. Spies, 2018, Genetics in Medicine.

GenVisR: Genomic Visualizations in R

Obi L. Griffith, Malachi Griffith, Alex H. Wagner, 2016, bioRxiv.

Standard operating procedure for somatic variant refinement of tumor sequencing data

Malachi Griffith, Obi L. Griffith, Sanjay Joshua Swamidass, 2018, bioRxiv.

DGIdb 2.0: mining clinically relevant drug–gene interactions

Deng Pan, Obi L. Griffith, Malachi Griffith, 2015, Nucleic Acids Res..

GenVisR: Genomic Visualizations in R

Malachi Griffith, Obi L. Griffith, Alex H. Wagner, 2016 .

Genome Modeling System: A Knowledge Management Platform for Genomics

Obi L. Griffith, Ken Chen, Vincent J. Magrini, 2015, PLoS Comput. Biol..

A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

Obi L. Griffith, Malachi Griffith, Nicholas C. Spies, 2015, Clinical Cancer Research.

Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma

Joshua F. McMichael, Zachary L. Skidmore, Christopher A. Miller, 2021, medRxiv.

Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.

Zachary L. Skidmore, O. Griffith, M. Griffith, 2021, PloS one.

Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Zachary L. Skidmore, Erica K. Barnell, Katie M. Campbell, 2021, Clinical Cancer Research.

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Zachary L. Skidmore, Erica K. Barnell, Katie M. Campbell, 2020, Clinical Cancer Research.

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer

Zachary L. Skidmore, O. Griffith, M. Ellis, 2017, Clinical Cancer Research.

Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

Joshua F. McMichael, Zachary L. Skidmore, Katie M. Campbell, 2023, Nature Communications.

Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer

Zachary L. Skidmore, Erica K. Barnell, Kelsy C. Cotto, 2022, Scientific Reports.

Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Zachary L. Skidmore, Katie M. Campbell, L. Trani, 2017, Bone.

Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer

Zachary L. Skidmore, O. Griffith, D. Hayes, 2022, iScience.

Comparative Multiomic Analysis Reveals Low T Cell Infiltration as the Primary Feature of Tobacco Use in HPV(+) Oropharyngeal Cancer

Zachary L. Skidmore, O. Griffith, D. Hayes, 2021, bioRxiv.

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Zachary L. Skidmore, O. Griffith, M. Ellis, 2021, Breast Cancer Research and Treatment.

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

Zachary L. Skidmore, Erica K. Barnell, Katie M. Campbell, 2020 .

Single Cell T Cell Receptor Repertoire Profiling for Dogs

Zachary L. Skidmore, R. Fulton, O. Griffith, 2021, bioRxiv.

Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma

Zachary L. Skidmore, Wesley C. Warren, O. Griffith, 2023, Frontiers in Veterinary Science.

Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers.

Zachary L. Skidmore, Erica K. Barnell, Christopher A. Miller, 2022, Cancer genetics.

Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers

Zachary L. Skidmore, Erica K. Barnell, Christopher A. Miller, 2021, bioRxiv.

A genomic case study of mixed fibrolamellar hepatocellular carcinoma

Zachary L. Skidmore, James M. Eldred, T. Graves, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

Zachary L. Skidmore, O. Griffith, M. Griffith, 2023, bioRxiv.

A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer

Zachary L. Skidmore, Erica K. Barnell, E. Mardis, 2017, Clinical Cancer Research.

Single-cell T-cell receptor repertoire profiling in dogs

Zachary L. Skidmore, O. Griffith, M. Griffith, 2024, Communications biology.